Atrial Firillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventr.docVIP

Atrial Fibrillation and Risk of Clinical Events in Chronic Heart Failure With and Without Left Ventricular Systolic Dysfunction Results From the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) Program Lars G. Olsson MB?, Karl Swedberg MD, PhD, FACC?, 1, , , Anique Ducharme MD, MSc?, 5, Christopher B. Granger MD, FACC?, 2, Eric L. Michelson MD, FACC§, 4, John J.V. McMurray MD, FACC, 1, Margareta Puu PhD?, 4, Salim Yusuf MD, DPhil, FACC#, 3, Marc A. Pfeffer MD, PhD, FACC??, 1 and CHARM Investigators ?Department of Medicine, Sahlgrenska University Hospi